Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 10/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.41 |
| ▸ | GPR6 | P46095 | 3/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.39 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2161363 | 0.96 | SCD (0.47) | SCDNPC1ALDH1A1GAARAB9A | |
| SCHEMBL2161494 | 0.94 | SCD (0.49) | SCDNPC1ALDH1A1GAARAB9A | |
| SCHEMBL2161316 | 0.94 | SCD (0.48) | SCDNPC1ALDH1A1GAARAB9A | |
| SCHEMBL12402057 | 0.93 | SCD (0.44) | SCDNPC1ALDH1A1GAARAB9A | |
| SCHEMBL2160513 | 0.93 | GPR6 (0.45) | SCDNPC1ALDH1A1GAARAB9A | |
| SCHEMBL12402062 | 0.92 | SCD (0.44) | SCDNPC1ALDH1A1GAARAB9A | |
| SCHEMBL2161900 | 0.92 | SCD (0.44) | SCDNPC1ALDH1A1GAARAB9A | |
| SCHEMBL12402063 | 0.91 | SCD (0.43) | SCDNPC1ALDH1A1GAARAB9A | |
| SCHEMBL2161313 | 0.91 | SCD (0.53) | SCDNPC1ALDH1A1GAARAB9A | |
| SCHEMBL2161016 | 0.91 | MEN1 (0.51) | SCDNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110183958-A1 | AZETIDINE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE | MERCK FROSST CANADA LTD. | 2011-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110183958-A1 | AZETIDINE DERIVATIVES AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE | SCD, SCD5, FADS2 | SCD 1/4885NPC1 199/4885ALDH1A1 394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.